Zynerba Pharmaceuticals, Inc. was a big mover last session, as its shares rose over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $14.09 to $19.20 in the past one-month time frame.

Over the last 30 days, the company witnessed one negative estimate revision while the Zacks Consensus Estimate also moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Zynerba Pharmaceuticals currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Zynerba Pharmaceuticals, Inc. Price

 

Zynerba Pharmaceuticals, Inc. Price | Zynerba Pharmaceuticals, Inc. Quote

A better-ranked stock in the medical-generic drugs space is Aquinox Pharmaceuticals, Inc. , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ZYNE going up? Or down? Predict to see what others think: Up or Down

Zacks' Top 10 Stocks for 2017

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?

Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>